Filter
1871
Filtered Results: 1871
Text search:
World
Health
Organization
WHO
and
World
Intellectual
Property
Organization
Featured
Recommendations
238
New Publications
380
Language
Document type
No document type
650
Studies & Reports
414
Guidelines
381
Manuals
221
Strategic & Response Plan
112
Training Material
52
Fact sheets
28
Situation Updates
7
Resource Platforms
4
Infographics
2
Countries / Regions
Global
161
India
36
South–East Asia Region
28
Africa
27
Western and Central Europe
27
Kenya
26
Ukraine
26
Uganda
24
South Africa
21
Ethiopia
21
Nepal
17
Ghana
17
Eastern Europe and Central Asia
16
Nigeria
14
Asia
13
Myanmar / Burma
13
Sierra Leone
12
West and Central Africa
12
East and Southern Africa
12
Bangladesh
12
Zambia
12
Syria
11
Malawi
11
Indonesia
11
Cambodia
10
Tanzania
10
Liberia
10
Rwanda
9
Middle East and North Africa
9
Western Pacific Region
8
Yemen
7
South Sudan
7
Lesotho
6
Afghanistan
6
Philippines
6
Eastern Europe
6
Thailand
5
Cameroon
5
Zimbabwe
5
Guinea
5
Mozambique
5
Latin America and the Carribbean
5
Congo, Democratic Republic of
5
Somalia
5
Pakistan
5
Iran
4
Haiti
4
Vietnam
4
Russia
4
Sudan
4
North Macedonia
3
Tajikistan
3
Kazakhstan
3
Laos
3
Burkina Faso
3
Germany
3
Lebanon
3
Sri Lanka
3
Colombia
2
Timor Leste/ East Timor
2
China
2
Kyrgyzstan
2
Peru
2
Venezuela
2
Lithuania
2
Jordan
2
Saudi Arabia
2
Côte d’Ivoire / Ivory Coast
2
Djibouti
2
Palestine
2
Georgia
2
Angola
2
Botswana
2
Iraq
2
Ecuador
2
North Korea
1
Mexico
1
Serbia
1
Turkey
1
Chile
1
Albania
1
Canada
1
Senegal
1
Estonia
1
Uzbekistan
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Armenia
1
USA
1
Paraguay
1
Japan
1
Denmark
1
Mauritius
1
Tunisia
1
Azerbaijan
1
Belarus
1
Bolivia
1
Papua New Guinea
1
Brazil
1
Namibia
1
Egypt
1
Greece
1
Mali
1
Chad
1
Libya
1
Bhutan
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
358
Clinical Guidelines
225
Public Health
168
Women & Child Health
137
Key Resources
136
Capacity Building
57
Pharmacy & Technologies
46
Toolboxes
Mental Health
184
HIV
151
COVID-19
149
Disability
141
TB
103
Caregiver
90
NTDs
89
Planetary Health
85
AMR
71
Rapid Response
58
Global Health Education
57
NCDs
42
Conflict
42
Pharmacy
41
Malaria
38
Health Financing Toolbox
32
Refugee
20
Ebola & Marburg
19
2.0 Rapid Response
15
Specific Hazards
10
Natural Hazards
8
Social Ethics
8
Polio
7
Zika
5
Cholera
3
The goal of the strategy is to prevent seasonal influenza, control the spread of influenza from animals to humans, and prepare for the next influenza pandemic.
The new strategy is the most comprehensive and far-reaching that WHO has ever developed for influenza. It outlines a path to protect popul...
Evidence from a systematic review on antenatal zinc supplementation was evaluated as part of the World Health Organization (WHO) antenatal care (ANC) guideline development process in 2016, and the following recommendation on zinc supplementation was made: “Zinc supplementation for pregnant women i...
This document aims to provide global guidance on poliomyelitis (polio) surveillance in the context of the COVID-19 pandemic. It comes as a technical complement to Polio eradication programme continuity, Immunization in the context of COVID-19 pandemic frequently asked questions, and is aligned with ...
This update of the Guidelines for poison control, entitled Guidelines for establishing a poison centre, reflects the development of the role of poison centres in public health and the sound management of chemicals, described in section 1, and the opportunities provided by new technology. Assessments...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for
additional funding and funders but also for the need to understand the current funding...
The present guidelines incorporate all these changes, leading to a substantial reconfiguration of therapeutic choices for both disease forms.
HAT is a serious, life-threatening disease and the efficacy of fexinidazole depends on swallowing the medicine after an appropriate intake of food as well as...
Operational guide: use of referral laboratories for the analysis of foodborne hazards in the Pacific
The Operational guide: use of referral laboratories for the analysis of foodborne hazards in the Pacific aims to strengthen the food analysis capacity of Pacific Island countries and areas by identifying national and reference laboratories capable of testing for priority foodborne hazards. The Pacif...
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ ex...
The country profiles incorporate facts indicating the national status of medical devices in areas such as: medical device policies, regulations, incorporation, lists, inventories, nomenclature, health technology assessment, management, and biomedical engineering resources. This publication is int...
Developmental disabilities are common. Yet, children with developmental disabilities have been neglected in health systems planning and policy provisions for health and continue to experience stigmatization, institutionalization, barriers to access health care and inequalities in health and educatio...
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan...
National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patterns are all influenced by gender.
Relapsing malaria caused by Plasmodium vivax parasites poses a significant challenge to global malaria elimination efforts. About one third of the population remains at risk of contracting P. vivax malaria, and 85% of P. vivax infections stem from reactivated latent parasites, leading to chronic ana...
Many critical questions remain about the effectiveness of COVID-19 vaccines in real-world settings. These questions can only be answered in post-introduction vaccine effectiveness studies.This guidance document outlines an approach to leverage existing surveillance systems for Severe Acute Respirato...
As of October 2017, the global database comprised almost 30 000 records, including results from bioassays to measure phenotypic resistance, and biochemical and molecular tests for resistance mechanisms. The current report presents an overview of data on malaria vector resistance for 2010 to 2016. It...
During the 17 years since Surgical approaches to the urogenital manifestations of lymphatic filariasis was first published, there has been heightened awareness of the physical, economic and emotional burden of the genitourinary manifestations of filariasis. With the impetus to provide better guidanc...
Tuberculosis (TB) control in the African Region has evolved since the disease was declared a global emergency by the World Health Organization (WHO) in 1993. Member States have adopted and implemented successive global and regional strategies and resolutions, with demonstrable positive impacts on in...
2nd edition. This second edition builds on the experience of more than 10 years of SMC deployment, and reflects changes introduced in the WHO guidelines for malaria, 3 June 2022. The goal of this publication is to share these best practices to improve SMC implementation, coverage, and monitoring and...
This guidance document has been produced by WHO to assist blood services in the development of national plans to respond to any emerging infectious threats to the sufficiency or safety of the blood supply, whether from an existing infectious agent that is changing in incidence and spread, or from a ...
